Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway

Jinbiao He; Yu Yang; Fan Zhang; Yanjuan Li; Xiaosi Li; Xuemei Pu; Xudong He; Mei Zhang; Xinxing Yang; Qiuman Yu; Yan Qi; Xuefang Li; Jie Yu

doi:10.3389/fphar.2023.1172950

Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway

Front Pharmacol. 2023 May 19:14:1172950. doi: 10.3389/fphar.2023.1172950. eCollection 2023.

Authors

Jinbiao He¹, Yu Yang¹, Fan Zhang¹, Yanjuan Li¹, Xiaosi Li¹, Xuemei Pu¹, Xudong He¹, Mei Zhang¹, Xinxing Yang¹, Qiuman Yu¹, Yan Qi¹, Xuefang Li¹, Jie Yu¹

Affiliation

¹ College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.1007274.].

Keywords: FXR/PPARα-SREBP pathway; MAFLD (metabolic-associated fatty liver disease); Poria cocos (Schw.) Wolf.; UPLC Q-TOF/MS; bile acid metabolism; lipid homeostasis.

Publication types

Published Erratum